An AR mediated lncRNA ZEB1-AS1 can promote cell stemness, proliferation, and invasion of cholangiocarcinoma [43], while AR inhibited lncRNA TMPO-AS1 can facilitate cell proliferation and migration, and correlate with poor prognosis in prostate cancer [44]. This evidence concerns the gene TMPO and prostate carcinoma.